Severe Systemic Lupus Erythematosus (SLE)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB11976 | Anifrolumab | A monoclonal antibody that inhibits type 1 interferon receptors, indicated in the treatment of moderate to severe systemic lupus erythematosus. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB11976 | Anifrolumab | Interferon alpha/beta receptor 1 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|